The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients
OncoTargets and Therapy2018Vol. Volume 11, pp. 4913–4944
Citations Over TimeTop 10% of 2018 papers
Zhijing Na, Xinbo Qiao, Xuanyu Hao, Ling Fan, Yao Xiao, Yining Shao, Mingwei Sun, Ziyi Feng, Guo Wen, Jiapo Li, Jiatong Li, Dongyang Li
Abstract
The present meta-analysis generally demonstrates no association between beta-blocker use and cancer prognosis except for CSS in all population groups examined. High-quality studies should be conducted to confirm this conclusion in future.
Related Papers
- → Comparing the Overall Result and Interaction in Aggregate Data Meta-Analysis and Individual Patient Data Meta-Analysis(2016)30 cited
- MiR-146a rs2910164 polymorphism is associated with hepatocellular carcinoma: a meta-analysis.(2015)
- → Network Meta-Analysis of the Antihypertensive Effect of Traditional Chinese Exercises on Patients with Essential Hypertension(2022)6 cited
- → Meta-analysis of the changes of peripheral blood regulatory T cell to CD4+ T cell ratio in patients with systemic sclerosis(2017)3 cited
- The polymorphism (Gln261Arg) of 12-lipoxygenase and cancer risk: a meta-analysis.(2015)